Michael Exton
Chief Executive Officer, Director at Lexicon Pharmaceuticals, Inc. (LXRX) since July 2024
Michael Exton has filed 6 insider reports with the SEC since July 2024, as chief Executive Officer and director at Lexicon Pharmaceuticals, Inc. (LXRX). In the last 12 months Michael Exton bought $50K of stock on the open market. In the latest filing, on November 9, 2026, Michael Exton bought 30,064 shares of Lexicon Pharmaceuticals, Inc. (LXRX) for $50K at an average of $1.66.
- Filings
- 6
- Companies
- 1
- Bought on market
- $50K
- Sold on market
- None
Companies where Michael Exton is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Directorsince July 2024 | 328,496 | $50K | $1.66 | $1.53-7.8% | Nov 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 6, 2026+$50KLXRXChief Executive Officer Exton Michael bought $49,999 worth of shares (30,064 units at $1.66), increasing direct ownership by 10% to 328,496 unitsForm 4Open-market purchase
- Feb 28, 2026LXRXChief Executive Officer Exton Michael covered exercise/tax liability with 204,831 shares and converted options into 503,263 sharesForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 12, 2026LXRXSEC Form 4 filed by Chief Executive Officer Exton MichaelForm 4Grant or award
- Feb 13, 2025LXRXSEC Form 4 filed by Chief Executive Officer Exton MichaelForm 4Grant or award
- Jul 8, 2024LXRXSEC Form 4 filed by Chief Executive Officer Exton MichaelForm 4Grant or award
- Jul 8, 2024LXRXMichael Exton became an insiderForm 3New insider
Compare Michael Exton with
- Michael Exton vs Judith L Swain1 shared
- Michael Exton vs Diane E. Sullivan1 shared
- Michael Exton vs Christopher J Sobecki1 shared
- Michael Exton vs Ivan Cheung1 shared
- Michael Exton vs Philippe Amouyal1 shared
- Michael Exton vs Sam L Barker1 shared
Other insiders at the same companies
- Judith L SwainLXRX
- Diane E. SullivanLXRX
- Christopher J SobeckiLXRX
- Ivan CheungLXRX
- Philippe AmouyalLXRX
- Sam L BarkerLXRX
- Raymond DebbaneLXRX
- Artal Participations S.A. r.l.LXRX
- Wendy McDermottLXRX
- Rachel Yap MartensLXRX
- Craig B GranowitzLXRX
- Suma GopinathanLXRX
- Lisa DeFrancescoLXRX
- Brian T CrumLXRX
- Scott M CoianteLXRX
- Avicenna Life Sci Master Fund LPLXRX
Questions about Michael Exton
- What is Michael Exton's role at Lexicon Pharmaceuticals, Inc.?
- Michael Exton reports to the SEC as chief Executive Officer and director at Lexicon Pharmaceuticals, Inc. (LXRX), according to the latest filing on November 9, 2026.
- How many shares does Michael Exton own?
- After the latest filing that states it, Michael Exton directly owned 328,496 shares of Lexicon Pharmaceuticals, Inc. (LXRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Exton bought or sold stock recently?
- The most recent open-market purchase was on November 6, 2026: bought 30,064 shares of Lexicon Pharmaceuticals, Inc. (LXRX) for $50K at an average of $1.66.
- How do I get alerts when Michael Exton files?
- Follow Michael Exton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Exton filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Michael Exton (SEC CIK 0002029249). Totals count each trade once, skipping amendments whose original is on file, from Jul 8, 2024 on. View on SEC EDGAR · Get this as JSON